Purchase Order 75F40123P00396
Award Date 9/11/23
Potential Completion Date 9/14/27
Potential Value $873K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $595,593.00 firm fixed price definitive contract for clinical site monitoring services for human subject research under the Center for Drug Evaluation and Research (CDER) program. The contract was awarded to Bracane Company, an 8(a) certified economically disadvantaged women-owned small business. The period of performance is from September 14, 2020 to September 14, 2023. Bracane Company is a research...
- The Food and Drug Administration issued a $310,220.30 delivery order to Bracane Company, an 8(a) Program Participant and Economically Disadvantaged Women-Owned Small Business, on May 5, 2026, under the Recall & Audit IDIQ Contract. The Recall & Audit IDIQ is a single-award, 8(a) sole-source indefinite delivery contract with an overall ceiling of $4 million and a contract end date of September 16, 2029. This is the third task order issued under that vehicle. Place of performance is...
- The U.S. Food and Drug Administration (FDA) awarded a $122,611.14 task order to Brillient Corporation, a minority-owned digital transformation company, under a Professional and Technical Services Blanket Purchase Agreement. The award, made on July 12, 2023, is designated as a Competitive 8(a) set-aside and is scheduled for completion by May 25, 2026. Work will be performed in Reston, Virginia, with pricing structured on a time and materials basis. The task order supports the FDA's Center for...
- The U.S. Food and Drug Administration (FDA) awarded a $92,321.14 firm fixed price purchase order to B-Bis LLC, a woman-owned small business, for safety program assessment services. The contract has an ultimate completion date of April 30, 2021. The original solicitation required the contractor to evaluate the FDA's safety program, including laboratory safety, environmental, occupational health care, ergonomics, automated external defibrillator (AED) program, non-laboratory personal safety, and...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to International Consulting Associates Inc. (ICA), an SBA-certified 8(a) small business. The $202,946.14 contract is for research to evaluate how the FDA's Center for Devices and Radiological Health (CDRH) assesses real-world evidence in regulatory submissions and identify best practices. ICA, a minority-owned small business, specializes in healthcare data...
- This is a sole-source, firm-fixed-price (FFP) purchase order awarded by the Food and Drug Administration (FDA) to Biomedical Research Alliance of New York LLC (BRANY) for a 5-year period of performance. The contract is for the provision of web-based training services to FDA personnel in areas such as human subjects research, responsible conduct of research, animal care and use, and good clinical practice. The contract has a ceiling value of $435,320.00 and does not have a set-aside...
- The U.S. Food and Drug Administration (FDA) awarded a delivery order valued at $129,081 to Realm Research LLC, a minority-owned small disadvantaged business, on September 23, 2025. This task order falls under a larger indefinite delivery contract with a $1.1 million ceiling established in September 2023 and is set to conclude on September 27, 2028. The work involves clinical site monitoring for FDA-funded human subject research studies conducted at various domestic and international locations,...
- This is a $4,075,658.29 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small business and Economically Disadvantaged Women-Owned Small Business (EDWOSB) certified in the SBA 8(a) program. The contract is for operations and maintenance services for the CDERONE (Center for Drug Evaluation and Research Operations) system, which supports regulatory review and evaluation processes for drugs. Agisol LLC has a history of providing IT services...
- The Food and Drug Administration awarded a delivery order valued at $266,359.20 to Mcneal Professional Services, Inc., a women-owned small business headquartered in Kennesaw, Georgia, for a Biologist I position. The contract, awarded on June 23, 2020, with completion targeted for July 9, 2022, is set aside for total small business and carries firm fixed-price pricing. Performance will take place at the FDA's Silver Spring, Maryland facility. Mcneal Professional Services holds SBA certification...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The $99,926.40 contract is for consulting services to support research and evaluation of electronic health records (EHR). ICA has an extensive track record providing data analytics, AI/ML, healthcare IT, and management consulting services to federal health...